Nextcure, Inc. · NASDAQ:NXTC
Simcere Zaiming, Inc. reported a 9.40% stake in Nextcure, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed May 6, 2026
Simcere Zaiming, Inc. reported a 9.40% stake in Nextcure, Inc., 338,636 shares, as a passive investor on Dec 31, 2025. Filed May 6, 2026 (Schedule 13G/A).
- Stake
- 9.40%
- Shares
- 338,636
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Simcere Zaiming, Inc. | 9.40% | 338,636 |
| Jiangsu Simcere Zaiming Pharmaceutical Co., Ltd. | 9.40% | 338,636 |
| Simcere Zaiming Pharmaceutical Co., Ltd. | 9.40% | 338,636 |
| Simcere Pharmaceutical Group Limited | 9.40% | 338,636 |
| Ren Jinsheng | 9.40% | 338,636 |
| Tang Renhong | 9.40% | 338,636 |
Source
Related
- Nextcure, Inc.
- Simcere Zaiming, Inc.
- Nextcure, Inc. shareholders
- Schedule 13G · Simcere Zaiming, Inc. · Aug 19, 2025
- Schedule 13G · JP Sailing Capital Ltd · Oct 20, 2026
- Schedule 13G · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Ikarian Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Squadron Capital Management LLC · Aug 14, 2026
- Schedule 13G/A · Affinity Asset Advisors, LLC · Aug 13, 2026